Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies

John Lew, Carmen C. Solorzano, Raquel E. Montano, Denise M. Carneiro-Pla, George L. Irvin

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: Many patients with sporadic primary hyperparathyroidism (SPHPT) have discordant preoperative Tc-99m-sestamibi (MIBI) and ultrasonography studies prior to focused parathyroidectomy (PTX). This study examines the usefulness of intraoperative parathormone monitoring (IPM) during PTX in patients with discordant preoperative localization studies. Methods: A retrospective series of 225 consecutive SPHPT patients with MIBI scans and surgeon performed ultrasonography (SUS) prior to focused parathyroidectomy were studied. All patient operations were reviewed, and how IPM changed operative management was determined. Correct gland localization, presence of multigland disease (MGD), and operative outcome were also examined. Results: In 225 patients, overall operative success was 97%, and IPM changed operative management in 29% of patients. In 85 patients (38%) with discordant studies, operative success was 93%; IPM changed operative management in 74% of these patients. IPM allowed for 66% (56/85) of these operations to be performed as unilateral neck exploration and confirmed removal of abnormal glands in 7 patients with MGD. In 140 patients (62%) with concordant localization, in which operative success was 99%, IPM changed operative management in only 2% (3/140) of these patients with MGD. Conclusion: Although of marginal benefit in patients with concordant imaging studies, IPM remains essential for performing successful PTX with discordant or incorrect concordant localization.

Original languageEnglish
Pages (from-to)299-306
Number of pages8
JournalSurgery
Volume144
Issue number2
DOIs
StatePublished - Aug 1 2008

Fingerprint

Intraoperative Monitoring
Parathyroidectomy
Parathyroid Hormone
Primary Hyperparathyroidism
Ultrasonography

ASJC Scopus subject areas

  • Surgery

Cite this

Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. / Lew, John; Solorzano, Carmen C.; Montano, Raquel E.; Carneiro-Pla, Denise M.; Irvin, George L.

In: Surgery, Vol. 144, No. 2, 01.08.2008, p. 299-306.

Research output: Contribution to journalArticle

Lew, John ; Solorzano, Carmen C. ; Montano, Raquel E. ; Carneiro-Pla, Denise M. ; Irvin, George L. / Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. In: Surgery. 2008 ; Vol. 144, No. 2. pp. 299-306.
@article{41fc25ae32ca4181a9dc85176e0ae040,
title = "Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies",
abstract = "Background: Many patients with sporadic primary hyperparathyroidism (SPHPT) have discordant preoperative Tc-99m-sestamibi (MIBI) and ultrasonography studies prior to focused parathyroidectomy (PTX). This study examines the usefulness of intraoperative parathormone monitoring (IPM) during PTX in patients with discordant preoperative localization studies. Methods: A retrospective series of 225 consecutive SPHPT patients with MIBI scans and surgeon performed ultrasonography (SUS) prior to focused parathyroidectomy were studied. All patient operations were reviewed, and how IPM changed operative management was determined. Correct gland localization, presence of multigland disease (MGD), and operative outcome were also examined. Results: In 225 patients, overall operative success was 97{\%}, and IPM changed operative management in 29{\%} of patients. In 85 patients (38{\%}) with discordant studies, operative success was 93{\%}; IPM changed operative management in 74{\%} of these patients. IPM allowed for 66{\%} (56/85) of these operations to be performed as unilateral neck exploration and confirmed removal of abnormal glands in 7 patients with MGD. In 140 patients (62{\%}) with concordant localization, in which operative success was 99{\%}, IPM changed operative management in only 2{\%} (3/140) of these patients with MGD. Conclusion: Although of marginal benefit in patients with concordant imaging studies, IPM remains essential for performing successful PTX with discordant or incorrect concordant localization.",
author = "John Lew and Solorzano, {Carmen C.} and Montano, {Raquel E.} and Carneiro-Pla, {Denise M.} and Irvin, {George L.}",
year = "2008",
month = "8",
day = "1",
doi = "10.1016/j.surg.2008.03.039",
language = "English",
volume = "144",
pages = "299--306",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies

AU - Lew, John

AU - Solorzano, Carmen C.

AU - Montano, Raquel E.

AU - Carneiro-Pla, Denise M.

AU - Irvin, George L.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Background: Many patients with sporadic primary hyperparathyroidism (SPHPT) have discordant preoperative Tc-99m-sestamibi (MIBI) and ultrasonography studies prior to focused parathyroidectomy (PTX). This study examines the usefulness of intraoperative parathormone monitoring (IPM) during PTX in patients with discordant preoperative localization studies. Methods: A retrospective series of 225 consecutive SPHPT patients with MIBI scans and surgeon performed ultrasonography (SUS) prior to focused parathyroidectomy were studied. All patient operations were reviewed, and how IPM changed operative management was determined. Correct gland localization, presence of multigland disease (MGD), and operative outcome were also examined. Results: In 225 patients, overall operative success was 97%, and IPM changed operative management in 29% of patients. In 85 patients (38%) with discordant studies, operative success was 93%; IPM changed operative management in 74% of these patients. IPM allowed for 66% (56/85) of these operations to be performed as unilateral neck exploration and confirmed removal of abnormal glands in 7 patients with MGD. In 140 patients (62%) with concordant localization, in which operative success was 99%, IPM changed operative management in only 2% (3/140) of these patients with MGD. Conclusion: Although of marginal benefit in patients with concordant imaging studies, IPM remains essential for performing successful PTX with discordant or incorrect concordant localization.

AB - Background: Many patients with sporadic primary hyperparathyroidism (SPHPT) have discordant preoperative Tc-99m-sestamibi (MIBI) and ultrasonography studies prior to focused parathyroidectomy (PTX). This study examines the usefulness of intraoperative parathormone monitoring (IPM) during PTX in patients with discordant preoperative localization studies. Methods: A retrospective series of 225 consecutive SPHPT patients with MIBI scans and surgeon performed ultrasonography (SUS) prior to focused parathyroidectomy were studied. All patient operations were reviewed, and how IPM changed operative management was determined. Correct gland localization, presence of multigland disease (MGD), and operative outcome were also examined. Results: In 225 patients, overall operative success was 97%, and IPM changed operative management in 29% of patients. In 85 patients (38%) with discordant studies, operative success was 93%; IPM changed operative management in 74% of these patients. IPM allowed for 66% (56/85) of these operations to be performed as unilateral neck exploration and confirmed removal of abnormal glands in 7 patients with MGD. In 140 patients (62%) with concordant localization, in which operative success was 99%, IPM changed operative management in only 2% (3/140) of these patients with MGD. Conclusion: Although of marginal benefit in patients with concordant imaging studies, IPM remains essential for performing successful PTX with discordant or incorrect concordant localization.

UR - http://www.scopus.com/inward/record.url?scp=47549088818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47549088818&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2008.03.039

DO - 10.1016/j.surg.2008.03.039

M3 - Article

C2 - 18656639

AN - SCOPUS:47549088818

VL - 144

SP - 299

EP - 306

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 2

ER -